Amino-Terminal Brain Natriuretic Peptide is Related to the Presence of Diabetic Polyneuropathy Independently of Cardiovascular Disease | Zendy

Jeroni Jurado | Zendy; Juan Ybarra | Zendy; Marı́a Luisa Ferrándiz | Zendy; Lourdes Comerma | Zendy; José María Pou | Zendy

Open Access

Amino-Terminal Brain Natriuretic Peptide is Related to the Presence of Diabetic Polyneuropathy Independently of Cardiovascular Disease

Author(s) -

Jeroni Jurado,

Juan Ybarra,

Marı́a Luisa Ferrándiz,

Lourdes Comerma,

José María Pou

Publication year - 2007

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc07-0890

Subject(s) - medicine , diabetes mellitus , polyneuropathy , disease , brain natriuretic peptide , natriuretic peptide , endocrinology , cardiology , heart failure

Diabetic polineuropathy (DPN) is among the most common long-term complications of diabetes, affecting up to 50% of patients (1,2). Type 2 diabetes is considered by many to be a cardiovascular disease (CVD) (3).Plasma levels of the NH2-terminal fragment of the brain natriuretic peptide (NT-proBNP) have recently gained extreme importance as markers of myocardial dysfunction in type 2 diabetes. Excessive secretion of NT-proBNP is independently associated with coronary artery disease and overt nephropathy (4) in addition …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research